FDA Reopens the Door to Moderna’s mRNA Flu Shot
Following a swiftly arranged meeting between the FDA and Moderna, the agency reconsidered last week's refusal of the company's filing. ...
Following a swiftly arranged meeting between the FDA and Moderna, the agency reconsidered last week's refusal of the company's filing. ...
The FDA has granted full approval of Spikevax for children aged 6 months through...
The Covid vaccine rollout coincided with the emergence of the entirely new medical phenomenon...
Bivalent mRNA vaccines for Covid produced by both Pfizer and Moderna apparently contain an...
The vaccine's efficacy is estimated to be less than 44 percent for infants, and...
Biotechnology company Moderna Therapeutics has launched a large-scale testing of its COVID jab on infants as...
This week, Denmark, Sweden, and Finland have suspended administering Moderna's COVID “Spikevax” vaccine over...
The Center for Disease Controls has scheduled an emergency meeting for June 18 to...